About Innovative strategies in inflammatory bowel disease
We aim to improve outcomes in inflammatory bowel disease by integrating patient-centered care, clinical innovation, smart technologies, and sustainable healthcare.
Research group leader
dr. Marjolijn Duijvestein
Internationally we are also known as
The Radboudumc IBD research group
Research programs
Programs that are connected to this research group.
Our members
-
Willemijn van Dop MDL arts
-
Mirjam Severs MDL arts
-
Dorien Oomkens arts promovendus MDL
-
Manal Aourag trialarts MDL